These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19502413)

  • 1. ApoCIII-enriched LDL in type 2 diabetes displays altered lipid composition, increased susceptibility for sphingomyelinase, and increased binding to biglycan.
    Hiukka A; Ståhlman M; Pettersson C; Levin M; Adiels M; Teneberg S; Leinonen ES; Hultén LM; Wiklund O; Oresic M; Olofsson SO; Taskinen MR; Ekroos K; Borén J
    Diabetes; 2009 Sep; 58(9):2018-26. PubMed ID: 19502413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of omega-3 carboxylic acids on apolipoprotein CIII-containing lipoproteins in severe hypertriglyceridemia.
    Morton AM; Furtado JD; Lee J; Amerine W; Davidson MH; Sacks FM
    J Clin Lipidol; 2016; 10(6):1442-1451.e4. PubMed ID: 27919362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan.
    Olin-Lewis K; Krauss RM; La Belle M; Blanche PJ; Barrett PH; Wight TN; Chait A
    J Lipid Res; 2002 Nov; 43(11):1969-77. PubMed ID: 12401896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanism for changes in proteoglycan binding on compositional changes of the core and the surface of low-density lipoprotein-containing human apolipoprotein B100.
    Flood C; Gustafsson M; Pitas RE; Arnaboldi L; Walzem RL; Borén J
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):564-70. PubMed ID: 14726411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein CIII bound to apoB-containing lipoproteins is associated with small, dense LDL independent of plasma triglyceride levels in healthy men.
    Shin MJ; Krauss RM
    Atherosclerosis; 2010 Jul; 211(1):337-41. PubMed ID: 20303494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteins.
    Mendivil CO; Zheng C; Furtado J; Lel J; Sacks FM
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):239-45. PubMed ID: 19910636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein CIII in apolipoprotein B lipoproteins enhances the adhesion of human monocytic cells to endothelial cells.
    Kawakami A; Aikawa M; Libby P; Alcaide P; Luscinskas FW; Sacks FM
    Circulation; 2006 Feb; 113(5):691-700. PubMed ID: 16461842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triglyceride-rich lipoproteins from subjects with type 2 diabetes do not demonstrate increased binding to biglycan, a vascular proteoglycan.
    Tannock LR; Olin KL; Barrett PH; Wight TN; Chait A
    J Clin Endocrinol Metab; 2002 Jan; 87(1):35-40. PubMed ID: 11788619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein C-III protein concentrations and gene polymorphisms in type 1 diabetes: associations with lipoprotein subclasses.
    Klein RL; McHenry MB; Lok KH; Hunter SJ; Le NA; Jenkins AJ; Zheng D; Semler AJ; Brown WV; Lyons TJ; Garvey WT;
    Metabolism; 2004 Oct; 53(10):1296-304. PubMed ID: 15375785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal accumulation of biglycan and lipid retention accelerates diabetic nephropathy.
    Thompson J; Wilson P; Brandewie K; Taneja D; Schaefer L; Mitchell B; Tannock LR
    Am J Pathol; 2011 Sep; 179(3):1179-87. PubMed ID: 21723246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional activation of apolipoprotein CIII expression by glucose may contribute to diabetic dyslipidemia.
    Caron S; Verrijken A; Mertens I; Samanez CH; Mautino G; Haas JT; Duran-Sandoval D; Prawitt J; Francque S; Vallez E; Muhr-Tailleux A; Berard I; Kuipers F; Kuivenhoven JA; Biddinger SB; Taskinen MR; Van Gaal L; Staels B
    Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):513-9. PubMed ID: 21183731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LDL containing apolipoprotein CIII is an independent risk factor for coronary events in diabetic patients.
    Lee SJ; Campos H; Moye LA; Sacks FM
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):853-8. PubMed ID: 12637336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E.
    Ebara T; Ramakrishnan R; Steiner G; Shachter NS
    J Clin Invest; 1997 Jun; 99(11):2672-81. PubMed ID: 9169497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the combination of methyltestosterone and esterified estrogens compared with esterified estrogens alone on apolipoprotein CIII and other apolipoproteins in very low density, low density, and high density lipoproteins in surgically postmenopausal women.
    Chiuve SE; Martin LA; Campos H; Sacks FM
    J Clin Endocrinol Metab; 2004 May; 89(5):2207-13. PubMed ID: 15126543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updates on apolipoprotein CIII: fulfilling promise as a therapeutic target for hypertriglyceridemia and cardiovascular disease.
    Zheng C
    Curr Opin Lipidol; 2014 Feb; 25(1):35-9. PubMed ID: 24345989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABCA1 promotes the de novo biogenesis of apolipoprotein CIII-containing HDL particles in vivo and modulates the severity of apolipoprotein CIII-induced hypertriglyceridemia.
    Kypreos KE
    Biochemistry; 2008 Sep; 47(39):10491-502. PubMed ID: 18767813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the proteoglycan binding site in apolipoprotein B48.
    Flood C; Gustafsson M; Richardson PE; Harvey SC; Segrest JP; Borén J
    J Biol Chem; 2002 Aug; 277(35):32228-33. PubMed ID: 12070165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertriglyceridemia but not diabetes status is associated with VLDL containing apolipoprotein CIII in patients with coronary heart disease.
    Lee SJ; Moye LA; Campos H; Williams GH; Sacks FM
    Atherosclerosis; 2003 Apr; 167(2):293-302. PubMed ID: 12818412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High binding affinity of electronegative LDL to human aortic proteoglycans depends on its aggregation level.
    Bancells C; Benítez S; Jauhiainen M; Ordóñez-Llanos J; Kovanen PT; Villegas S; Sánchez-Quesada JL; O O Rni K
    J Lipid Res; 2009 Mar; 50(3):446-455. PubMed ID: 18952981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of plasma apolipoprotein CIII, high sensitivity C-reactive protein and tumor necrosis factor-α contributes to the clinical features of coronary heart disease in Li and Han ethnic groups in China.
    Chen L; Sun M; Liu H; Ma L; Wang T; Li P; Lin M; Lin H; Chang P; Liu Y
    Lipids Health Dis; 2018 Jul; 17(1):176. PubMed ID: 30053815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.